Clinical Trial Update: Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating artificial intelligence approaches for treating neovascular age-related macular degeneration in real-world settings; curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: Medical University of Vienna | Conditions: Exudative Macular Degeneration | Phase 4 | Status: RECRUITING